- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
1990
Modi-Mundipharma Ltd. is an Indian international pharmaceutical company with its headquarters in New Delhi, India. The company was established in the year 1990 and was the result of another joint venture of the Umesh Modi Group with the Swiss giant Mundipharma Group. The Umesh Modi Group is a large firm that was established by founder Rai Bahadur Gujarmal Modi and started operating in pharmaceutical business in 1982. The group has successfully executed several tie-ups to improve its presence in the Indian pharmaceutical sector. One such joint venture was that of Win Medicare Private Limited which is another Indian multinational pharmaceutical company under it and is headquartered in Delhi, India. The Swiss giant Mundipharma is quite reputed in the pharmaceutical industry because of its efficient research facilities and manufacturing affiliation with the Napp Pharmaceutical Group in the UK and Purdue Frederick Co. in the USA. Modi-Mundipharma Ltd. has a strong presence in the therapy areas of asthma, pain management and cardiovascular diseases. The company was incorporated on the 31st of October in the year 1990. The company has made distribution agreements with the Italian company Zambon and Sigma-Tau, Netherlands-based company Norgine, USA-based Anika Therapeutics and Lavipharm, which is in Greece.
The company specializes in the therapy areas of asthma, pain management, gynecology, cardiovascular diseases, respiratory diseases, urology, analgesics, antiseptics, arthritis, nutraceuticals and cardiovascular diseases. Modi-Mundipharma Ltd. has achieved its presence in various therapy areas through its in-licensing agreements with its global partners.
Modi-Mundipharma Ltd. which falls under the Umesh Modi Group gets its production and research and development facilities both, from those loacted within the country as well as from international locations. The company has a very strong position in Research and Development and makes use of the Continus Technology in its therapy areas. While its global locations include the countries USA, Germany and Switzerland, the company has its domestic manufacturing plants located in Modipuram, Modinagar, Rudrapur, Bangladesh, Behror and Malakpur. The company has a large number of business partnerships with major international companies and its global footprint can be said to exist in countries like Switzerland, Netherlands, Italy, Korea, USA, France, Germany and Greece.
Some of the top products of the company are NITROCONTIN, UNICONTIN-E, BUVALOR, MONUROL, TRD-CONTIN, DILCONTIN, FECONTIN-Z, PYRICONTIN, FECONTIN-F, TAMCONTIN, TRIMACONTIN, ACOCONTIN, PEGICOL, SOYGROWTH, PYRICONTIN-F, TAMCONTIN-D, TRD-MD, FLUIMUCIL, TRD-CONJECT, CEBOCONTIN, ALPROCONTIN, DOLOPENT, MONOVISC, DIUCONTIN-K, LEVOCARNIL, DOLMUNDIN, TRD-P, VIDASLIM, SUPERFOS, LIDOVALOR, INDICONTIN, ACONAME, STAWIN, MORCONTIN, BETASEPTIC, VALCONTIN, PHYLLOCONTIN, TOLCONTIN, MONOCONTIN, DOLOFORT and LOLCONTIN-M.
Umesh Modi Group
Umesh Modi Group
The contact details of the company are:
Tel:+91-11-42504555
Email: info@umeshmodigroup.com